The history of the hepatitis B vaccine has been marked by controversies, from the ‘Australia antigen’ to the ‘Pediatric ...
Hosted on MSN
WHO declares Hepatitis D virus as "carcinogenic": What does this mean amidst rising liver diseases
The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have classified the hepatitis D virus (HDV) as carcinogenic to humans. HDV has joined hepatitis B and C ...
Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in hepatitis B while it seeks a suitable partner. Back in November, Vir arrived ...
Hosted on MSN
How Hepatitis D virus can cause liver cancer: Know its symptoms, risks, causes, and more
The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have officially classified the Hepatitis D virus (HDV) as carcinogenic to humans. This places HDV ...
The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...
Hepatitis B is a serious liver disease caused by the hepatitis B virus (HBV), which is a small DNA virus from the Hepadnaviridae family. If someone has this infection for a long time, it can lead to ...
We know the virus is most commonly passed from mother to child at birth or through contact with infected blood and bodily fluids, 5 with infants facing the highest risk of lifelong chronic infection ...
A key federal vaccine advisory panel whose members were recently replaced by Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is expected to vote to recommend delaying ...
Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the benefits of vaccination. The company—which makes hepatitis B vaccine ...
Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection ...
Guinea-Bissau's health minister says the government is suspending a Trump administration-backed hepatitis B vaccine study on newborns in the West African country pending an ethical review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results